Sellas Life Sciences Group Inc (SLS NASDAQ) stock market data APIs
$5.0093
-0.05(-1%)
as of May 4, 2026
Try our APIs with
free plan!
Sellas Life Sciences Group Inc Financial Data Overview
Price chart is built with
Anychart
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Prev. Close
5.0093
Open
4.9605
High
5.2315
Low
4.9585
52 wk Range
1.36-6.14
Market Cap
926 M
Shares Outstanding
185 M
EPS
-0.05
Beta
2.244
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Sellas Life Sciences Group Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sellas Life Sciences Group Inc data using free add-ons & libraries
Get Sellas Life Sciences Group Inc Fundamental Data
Sellas Life Sciences Group Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Sellas Life Sciences Group Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-03-13
- EPS/Forecast: -0.07
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sellas Life Sciences Group Inc News
New
The Copper Bottleneck That Rewrites Mining Valuations
VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — The world needs copper faster than it can find it. Latin America's mining sector is pulling in re...
SELLAS Life Sciences Group Inc. (SLS) Making Progress on Key Acute Myeloid Leukemia Treatment
Sellas Life Sciences Group Inc. (NASDAQ:SLS) is one of the best healthcare penny stocks to buy according to hedge funds. On March 19, Chief Executive Officer Angelos Stergiou reiterated that 2026 is p...
Solaris Secures EIA Technical Approval and Further Strengthens the Balance Sheet
Solaris Resources HIGHLIGHTS OF THE PRESS RELEASE: EIA Technical Approval Received – Major permitting milestone achieved following a comprehensive multi-year government review, significantly de-ri...
These 16 stocks are a short seller’s dream — likely losers no matter what the market does
- Getty Images/iStockphoto Certain stocks are good bets to lag the market in the coming months, according to a new study, regardless of what the market does. Sixteen of these stocks are listed in a t...
Get Sellas Life Sciences Group Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
